Source link : https://newshealth.biz/health-news/common-meds-linked-to-reduced-immunotherapy-benefit-in-lung-cancer-trial/
(MedPage Today) — Exposure to proton pump inhibitors (PPIs) was associated with worse progression-free survival (PFS) and overall survival (OS) in patients with locally advanced non-small cell lung cancer (NSCLC) who were treated with durvalumab… Source link : https://www.medpagetoday.com/hematologyoncology/lungcancer/122068 Author : Publish date : 2026-07-06 20:38:00 Copyright for syndicated content belongs to the linked Source.
The post Common Meds Linked to Reduced Immunotherapy Benefit in Lung Cancer Trial first appeared on News Health.
—-
Author : News Health
Publish date : 2026-07-06 20:38:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8